Detalhe da pesquisa
1.
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis.
Mult Scler
; 27(13): 2001-2013, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34612753
2.
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
Mult Scler
; 27(2): 220-231, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32255388
3.
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
Eur J Neurol
; 28(10): 3418-3425, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34080271
4.
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
Mult Scler
; 25(4): 541-553, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29143562
5.
Serum lipid profile changes predict neurodegeneration in interferon-ß1a-treated multiple sclerosis patients.
J Lipid Res
; 58(2): 403-411, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27923871
6.
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
Mult Scler
; 23(1): 51-61, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27053635
7.
Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?
Mult Scler
; 23(2): 242-252, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27230790
8.
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
Eur J Neurol
; 29(1): e7-e8, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699086
9.
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
Mult Scler
; 22(6): 770-81, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362893
10.
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
Mult Scler
; 22(13): 1709-1718, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26883943
11.
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients.
J Lipid Res
; 56(10): 2010-8, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26243484
12.
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes.
J Neurol Neurosurg Psychiatry
; 85(8): 859-64, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24470599
13.
Thalamic atrophy is associated with development of clinically definite multiple sclerosis.
Radiology
; 268(3): 831-41, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23613615
14.
Lipid profiles are associated with lesion formation over 24 months in interferon-ß treated patients following the first demyelinating event.
J Neurol Neurosurg Psychiatry
; 84(11): 1186-91, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23595944
15.
Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab.
Front Immunol
; 14: 1149629, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398654
16.
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
Neurology
; 100(7): e671-e682, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270895
17.
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection.
Mult Scler Relat Disord
; 65: 104014, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803085
18.
Monitoring of radiologic disease activity by serum neurofilaments in MS.
Neurol Neuroimmunol Neuroinflamm
; 7(4)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273481
19.
Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.
J Clin Lipidol
; 14(5): 675-684.e2, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32758395
20.
Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study.
Neuroimage Clin
; 17: 444-451, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29159057